Health Care & Life Sciences » Pharmaceuticals | GreenPeptide Co. Ltd.

GreenPeptide Co. Ltd.

GreenPeptide Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY44.96
Market Cap
JPY11.63 B
Shares Outstanding
41.99 M
Public Float
40.61 M

Profile

Address
Fukuoka Bio Incubation Center 402
Kurume Fukuoka 839
Japan
Employees -
Website http://www.brightpathbio.com
Updated 07/08/2019
BrightPath Biotherapeutics Co., Ltd. engages in the drug development business. It focuses on the development of cancer immunotherapies. Its product candidates are based on peptide vaccine technology that stimulates a potent immune response to tumor-associated antigens.

Financials

View All

Kenichi Nagai
President, CEO & Representative Director
Yutaka Waki
COO, Director & Manager-Medicine Development